Table 1.
Demographic, clinical, imaging, interventional, and sampling related characteristics (n = 61).
Demographics | n = 61 |
---|---|
Age [years], median (IQR) | 77 (68–83) |
Male sex, n (%) | 23 (38%) |
Medical history | |
Hypertension, n (%) | 54 (89%) |
Diabetes mellitus, n (%) | 12 (20%) |
Hyperlipidemia, n (%) | 19 (31%) |
Atrial fibrillation, n (%) | 35 (57%) |
Current smoker, n (%) | 5 (8%) |
Baseline medication | |
Antithrombotic medication, n (%) | 30 (49%) |
Antihypertensive drugs, n (%) | 50 (82%) |
Clinical characteristics | |
Systolic blood pressure [mmHg], median (IQR) | 160 (150–180) |
Diastolic blood pressure [mmHg], median (IQR) | 85 (71–96) |
Heart rate [min-1], median (IQR) | 80 (69–90) |
NIHSS at presentation, median (IQR) | 15 (10–17) |
Unknown time of symptom onset, n (%) | 14 (23%) |
Qualifying ASPECTS, median (IQR) | 8 (7–9) |
Treatment | |
Thrombolysis | |
IV rt-PA, n (%) | 25 (41%) |
Intervention | |
Onset-to-puncture [min], median (IQR) | 255 (170–343) |
Angiographic occlusion location∗ | |
M1, n (%) | 44 (72%) |
M2, n (%) | 14 (23%) |
ICA, n (%) | 10 (16%) |
Stent-retrieval maneuvers, median (IQR) | 2 (1–3) |
Successful recanalization, n (%)† | 54 (89%) |
Onset-to-recanalization time [min], median (IQR) | 322 (245–389) |
Sampling | |
Onset-to-ischemic sampling time [min], median (IQR) | 282 (200–367) |
Onset-to-systemic sampling time [min], median (IQR) |
325 (261–401) |
Ischemic-to-systemic sampling time [min], median (IQR) | 33 (18–69) |
ASPECTS, Alberta Stroke Program Early CT score; IV rt-PA, intravenous recombinant tissue plasminogen activator; NIHSS, National Institutes of Health Stroke Scale; ∗Including multiple sites per patient; M1/M2, middle cerebral artery section; ICA, internal carotid artery; †definied as mTICI (modified treatment in cerebral infarction) scale 2b or 3.